2-Amino-5-methylpyridine | CAS:1603-41-4

We serve 2-Amino-5-methylpyridine CAS:1603-41-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Amino-5-methylpyridine

Chemical Name:2-Amino-5-methylpyridine
CAS.NO:1603-41-4
Synonyms:2-Amino-5-methylpyridine
2-Amino-5-Methylpyridine
5-Methyl-2-pyridinamine
5-methylpyridin-2-amine
2-Amino-5-picoline
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 227.0±0.0 °C at 760 mmHg
Melting Point 76-77 °C(lit.)
Molecular Formula C6H8N2
Molecular Weight 108.141
Flash Point 110.9±9.0 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.574
 
Specification:
Appearance:White to yellowish crystalline powder
Assay:≥99.0%
Moisture:≤0.5%
Melting Point:75-81°C
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Acetaniprid(CAS:135410-20-7).



Contact us for information like 2-Amino-5-methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-5-picoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Methyl-2-pyridinamine Use and application,2-Amino-5-methylpyridine technical grade,usp/ep/jp grade.


Related News: Speaking to Sky News, Raab said he could not confirm the “precise number” of those arriving into the UK on Sunday.p-aminodiphenylamine manufacturer Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days.4-Amino-3-fluoropyridine supplier Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships.pentane-2,3-dione vendor Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”